LINC01525: A Non-Coding RNA Molecule as a Potential Drug Target and Biomarker

Target Name: LINC01525

NCBI ID: G104355292

LINC01525

Other Name(s): lnc-MAN1A2-1 | long intergenic non-protein coding RNA 1525 | Long intergenic non-protein coding RNA 1525

LINC01525: A Non-Coding RNA Molecule as a Potential Drug Target and Biomarker

LINC01525 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and functional characteristics make it an intriguing target for researchers to study.

The LINC01525 molecule is a long non-coding RNA molecule that is approximately 290 nucleotides in length. It is expressed in various tissues and cells of the body and is known to play a role in various cellular processes, including cell growth, differentiation, and RNA processing.

One of the key features of the LINC01525 molecule is its ability to interact with other molecules and proteins. It has been shown to interact with various proteins, including the transcription factor, p53, and the protein, NEDD8. These interactions suggest that the LINC01525 molecule may play a role in regulating gene expression and that it may be a useful target for drugs that target these processes.

Another feature of the LINC01525 molecule is its ability to form a complex with small nucleolar planets (SNPs). SNPs are small genetic variations in the DNA sequence that occur frequently in the human genome. These SNPs can interact with the LINC01525 molecule and form a stable complex, which suggests that the LINC01525 molecule may be a useful biomarker for detecting SNPs in cancer cells.

In addition to its potential role as a drug target and biomarker, the LINC01525 molecule has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that LINC01525 is downregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, the LINC01525 molecule has been shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells.

Given its unique structure and functional characteristics, the LINC01525 molecule has the potential to be a valuable drug target and biomarker for various diseases. Researchers are currently working to develop compounds that can specifically target the LINC01525 molecule and to study its role in different diseases.

In conclusion, LINC01525 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and functional characteristics make it an intriguing target for researchers to study, and its potential as a drug and biomarker makes it an important area of research for the development of new treatments for a variety of diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1525

The "LINC01525 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01525 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets